Literature DB >> 16266700

New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence.

Falk Kiefer1, Karl Mann.   

Abstract

The treatment of alcohol dependence mainly consists of psychological, social, and pharmacotherapeutic interventions aiming to reduce physical withdrawal, craving, and alcohol relapse. During the last years, it has become increasingly clear that adjuvant pharmacotherapy is efficacious especially in rehabilitation programs for alcohol dependent patients. The development of alcohol dependence seems to involve adaptive changes in amino acid neurotransmitter systems, stimulation of dopamine and opioid peptide systems, and changes in serotonergic activity. Disulfiram, naltrexone and acamprosate are approved treatments for the management of abstinence maintenance treatment. New compounds are under investigation. This review discusses the neurobiological basis of alcohol addiction, pharmacological targets for relapse prevention treatment and pre-clinical and clinical results with the most promising drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16266700     DOI: 10.1016/j.ejphar.2005.09.028

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  [Evidence-based psychotherapy: addiction and personality disorders as comorbidities].

Authors:  T Kienast; E Roediger; M Kensche; J Foerster; I Daig; A Heinz
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

Review 2.  Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication?

Authors:  Asli F Ceylan-Isik; Shawna M McBride; Jun Ren
Journal:  Life Sci       Date:  2010-06-16       Impact factor: 5.037

3.  Different phenotypic and genotypic presentations in alcohol dependence: age at onset matters.

Authors:  Yu-Chu Chen; Carol A Prescott; Dermot Walsh; Diana G Patterson; Brien P Riley; Kenneth S Kendler; Po-Hsiu Kuo
Journal:  J Stud Alcohol Drugs       Date:  2011-09       Impact factor: 2.582

Review 4.  [Pharmacological relapse prevention in alcohol and tobacco dependence].

Authors:  A Diehl; K Mann
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

Review 5.  [Evidence-based treatment of alcoholism].

Authors:  F Kiefer; K Mann
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

6.  Effects of the mGluR2/3 agonist LY379268 and the mGluR5 antagonist MPEP on handling-induced convulsions during ethanol withdrawal in mice.

Authors:  M Foster Olive; Howard C Becker
Journal:  Alcohol       Date:  2008-05       Impact factor: 2.405

7.  Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake.

Authors:  Martin Weber; Sonja Talmon; Ilka Schulze; Christine Boeddinghaus; Gerhard Gross; Hans Schoemaker; Karsten M Wicke
Journal:  Psychopharmacology (Berl)       Date:  2008-12-23       Impact factor: 4.530

8.  Disulfiram-induced transient optic and peripheral neuropathy: a case report.

Authors:  A Orakzai; M Guerin; S Beatty
Journal:  Ir J Med Sci       Date:  2007-09-05       Impact factor: 1.568

9.  Acute interaction of baclofen in combination with alcohol in heavy social drinkers.

Authors:  Suzette M Evans; Adam Bisaga
Journal:  Alcohol Clin Exp Res       Date:  2008-10-06       Impact factor: 3.455

10.  Protective effect of Terminalia arjuna against alcohol induced oxidative damage of rat erythrocyte membranes.

Authors:  Ananda Vardhan Hebbani; Damodara Reddy Vaddi; Padma Priya Dd; Varadacharyulu NCh
Journal:  J Ayurveda Integr Med       Date:  2021-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.